What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma

Journal of Neuro-Oncology

Volumn 91, Issue 2, 2009, Pages 117-125

  Amarasingh, S ^a   Macleod, Malcolm R ^a   Whittle, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

BCNU; CCNU; Experimental glioma model; Glioma chemotherapy

Indexed keywords

CARMUSTINE; LOMUSTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER RESEARCH; DOSE RESPONSE; DRUG EFFICACY; DRUG RESEARCH; EFFECT SIZE; EPENDYMOBLASTOMA; EXPERIMENTAL DESIGN; GLIOMA; GLIOSARCOMA; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL RATE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION; GLIOMA; HUMANS; LOMUSTINE; META-ANALYSIS AS TOPIC;

EID: 57349166617     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9697-z     Document Type: Article

References (53)

1. Cheng CJ, Fujimara S, Grunberger D, Weinstein IB (1972) Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea with nucleic acids and proteins in vivo and in vitro. Cancer Res 32:22-27
2. Kann HE, Kohn KW, Widerlite L, Gullion D (1974) Effects of 1,3-Bis(2-chloroethyl)-1-nitrosourea and related compounds on nuclear RNA metabolism. Cancer Res 34:1982-1988
3. Wheeler GP, Bowdon BJ, Grimsley JA, Lloyd HH (1974) Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 34:194-200
4. Levin VA, Shapiro WR, Clancy TP, Oliverio VT (1970) The uptake, distribution and antitumour activity of 1-(2-chloroethyl)-3-cyclohexy-1-nitrosourea in the murine glioma. Cancer Res 30:2451-2455
5. Chirigos MA, Humphreys SR, Goldin A (1965) Duration of effective levels of three antitumor drugs in mice with leukaemia L1210 implanted intracerebrally and subcutaneously. Cancer Chemother Rep 49:15-19
6. Schabel FM, Johnston TP, McCaleb GS et al (1963) Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukaemia. Cancer Res 23:725-733
7. Ausman JI, Shapiro WR, Slivaka JJ (1968) The effect of chemotherapeutic agents on an experimental mouse brain tumour. Proc Am Assoc Cancer Res 9:4
8. Shapiro WR, Ausman JI (1969) Effect of chemotherapeutic agents on experimental brain tumours. Proc Am Assoc Cancer Res 10:79
9. Rosso R, Donelli MG, Innocenti R-D, Garattini S (1967) Chemotherapy of tumours transplanted intracerebrally. Eur J Cancer 3:125-137. doi: 10.1016/0014-2964(67)90034-5
10. Carter SK, Newman JW (1968) Nitrosoureas: 1, 3-Bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea - clinical brochure. Cancer Chemother Rep 1:115-151
11. Geran RI, Congleton GF, Dudeck LE, Abbott BJ, Gargus JL (1974) A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Cancer Chemother Rep 2 4:53-87
12. Houchens DP, Ovejera AA, Riblet SM (1981) Human brain tumor xenografts in nude mice as a model for chemotherapy and/or immunotherapy. Proc Am Assoc Cancer Res 22:975
13. Shapiro WR, Ausman JI, Rall DP (1970) Studies on the chemotherapy of experimental brain tumors: Evaluation of 1, 3-Bis(2-chloroethyl)-1-nitrosourea, cyclo-phosphamide, mithramycin, and methotrexate. Cancer Res 30:2401-2413
14. Barker M, Hoshino T, Gurcay O et al (1973) Development of an animal brain tumour model and its response to therapy with 1, 3-Bis(2-chloroethyl)-1-nitrosourea. Cancer Res 33:976-986
15. Schold SC Jr, Rawlings CEIII, Bigner SH, Bigner DD (1983) Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1, 3-Bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzquinone, and cis-platinum. Neurosurgery 12(6):672-677. doi: 10.1097/00006123-198306000-00014
16. Bradford R, Darling JL, Thomas DGT (1990) The chemotherapeutic response of a murine (VM) model of human glioma. Br J Cancer 61:46-50
17. Houchens DP, Ovejera AA, Riblet SM, Slagel DE (1983) Human brain tumor xenografts in nude mice as a chemotherapy model. Eur J Cancer Clin Oncol 19:799-805. doi: 10.1016/0277-5379(83)90012-3
18. Shapiro WR, Basler GA, Chernik NL, Posner JB (1979) Human brain tumour transplantation into nude mice. J Natl Cancer Inst 62:447-453
19. Bullard DE, Bigner SH, Bigner DD (1985) Comparison of intravenous versus intracarotid therapy with 1,3-Bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Cancer Res 45:5240-5245
20. Tator CH, Day A, Ng R, Liberman L (1977) Chemotherapy of an experimental glioma with nitrosoureas. Cancer Res 37:476-481
21. Tamura M, Mennel HD, Zülch KJ (1979) Brain tumour chemotherapy using a rat glioma model. J Cancer Res Clin Oncol 94:39-46. doi: 10.1007/ BF00405348
22. Shapiro WR (1971) Studies on the chemotherapy of experimental brain tumors: Evaluation of 1-(2-chloroethyl)-3-cyclohexy-1-nitrosourea, vincristine and 5-fluorouracil. J Natl Cancer Inst 46:359-368
23. Waldbaur H, Kuschnir H, Engelmann U, Schmidt H, Schmack B (1978) Experiments on the chemotherapy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Acta Neurochir (Wien) 42:103-108. doi: 10.1007/BF01406636
24. Shapiro WR (1972) Effect of 1-(2-chloroethyl)-3-cyclohexy-1-nitrosourea in sesame oil administered intramuscularly in the treatment of experimental brain tumors. Cancer Chemother Rep 56:457-463
25. Mennel HD, Hellwig D, Simon H (1986) Chemotherapy in intracerebrally transplanted tumors induced with transplacental administration of ethylnitrosourea in rats. J Cancer Res Clin Oncol 112:240-244. doi: 10.1007/BF00395918
26. Bullard DE, Schold SC Jr, Bigner SH, Bigner DD (1981) Growth and chemotherapeutic response in athymic mice of tumors arising from glioma-derived cell lines. J Neuropathol Exp Neurol 40:410-427. doi: 10.1097/00005072-198107000-00005
27. Schold SC Jr, Bigner DD (1983) Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine and mithramycin. Cancer Treat Rep 67(9):811-819
28. Walker MD, Alexander E Jr, Hunt WE (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333-343
29. Wilson CB, Boldrey EB, Enot KJ (1970) 1,3-Bis(2-chloroethyl)-1-nitrosourea in the treatment of brain tumors. Cancer Chemother Rep 54:273-282
30. Anderson E, Grant R, Lewis S, Whittle IR (2008) Randomized phase III controlled trials of therapy in malignant glioma: Where are we after 40 years? Br J Neurosurg 22:339-349. doi: 10.1080/02688690701885603
31. Stewart LA (2002) Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018. doi: 10.1016/S0140-6736(02)08091-1
32. Bredel M (2001) Anticancer drug resistance in primary human brain tumours. Brain Res Brain Res Rev 35:161-201. doi: 10.1016/ S0165-0173(01)00045-5
33. Perel P, Roberts I, Sena E et al (2007) Comparison of treatment effects between animal experiments and clinical trials: Systematic review. BMJ 334(7586):197. doi: 10.1136/bmj.39048.407928.BE
34. Crossley NA, Sena E, Goehler J et al (2008) Empirical evidence of bias in the design of experimental stroke studies: A metaepidemiologic approach. Stroke 39(3):929-934. doi: 10.1161/STROKEAHA.107.498725
35. Sena E, van der Worp HB, Howells D, Macleod M (2007) How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 30(9):433-439. doi: 10.1016/j.tins.2007.06.009
36. van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR (2007) Hypothermia in animal models of acute ischaemic stroke: A systematic review and meta-analysis. Brain 130(Pt 12):3063-3074
37. Horn J, de Haan RJ, Vermeulen M et al (2001) Nimodipine in animal model experiments of focal cerebral ischemia: A systematic review. Stroke 32(10):2433-2438. doi: 10.1161/hs1001.096009
38. Wheble PC, Sena ES, Macleod MR (2008) A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis 25(1-2):5-11. doi: 10.1159/ 000111493
39. Candolfi M, Curtin JF, Nichols WS et al (2007) Intracranial glioblastoma models in preclinical neuro-oncology: Neuropathological characterization and tumor progression. J Neurooncol 85:133-148. doi: 10.1007/ s11060-007-9400-9
40. Whittle IR, Macarthur DC, Malcolm GP et al (1998) Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours. J Neurooncol 36(3):231-242. doi: 10.1023/ A:1005831111337
41. Culver KW, Ram Z, Wallbridge S et al (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256(5063):1550-1552
42. King GD, Curtin JF, Candolfi M et al (2005) Gene therapy and targeted toxins for glioma. Curr Gene Ther 5:535-557
43. Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11(17):2389-2401
44. Whittle IR (1995) Gene therapy for brain tumours. Br J Neurosurg 9(6):717-720
45. Bell H, Kimber WL, Li M, Whittle IR (1998) Liposomal transfection efficiency and toxicity on glioma cell lines: In vitro and in vivo studies. Neuroreport 9(5):793-798
46. Macleod MR, O'collins T, Howells DW, Donnan GA (2004) Pooling of animal experimental data reveals influence of study-design and publication bias. Stroke 35:1203-1208
47. Greenhalgh T (2001) How to read a paper, 2nd edn. BMJ Publishing Group, London
48. Katz ME, Glick JH (1979) Nitrosoureas: A reappraisal of clinical trials. Cancer Clin Trials 2:297-316
49. Macleod MR, O'Collins T, Horky LL et al (2005) Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. Cereb Blood Flow Metab 25(6):713-721
50. Begg C, Cho M, Eastwood S et al (1996) Improving the quality of reporting of randomised controlled trials. The CONSORT statement. JAMA 276:637-639
51. Chin HW, Young AB, Maruyama Y (1981) Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky. Cancer Treat Rep 65:45-51
52. Reagan TJ, Bisel HF, Childs DS et al (1976) Controlled study of CCNU and radiation therapy in malignant glioma. J Neurosurg 44(2):189-190
53. Weir B, Band P, Urtasun R et al (1976) Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytoma. J Neurosurg 45(2):129-134